Friday, 27 March 2015

Aptamers Market Expected to Reach USD 4.33 Billion Globally in 2019


According to a new market report published by Transparency Market Research Aptamers Market (By Types - Nucleic Acid Aptamers and Peptide Aptamers; By Applications - Therapeutics Development, Diagnostics, Research and Development Applications and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019, the global aptamers market was valued at USD 93.0 million in 2012 and is estimated to reach USD 4,333.0 million in 2019, growing at a CAGR of 73.1% from 2013 to 2019.

Browse the full Aptamers Market report at http://www.transparencymarketresearch.com/aptamers-market.html

Aptamers are single-stranded nucleic acid oligonucleotide or peptide molecules. Aptamers can bind with a range of target molecules such as proteins, carbohydrates, ions and viruses. Aptamer technology is widely used in laboratory diagnosis, molecular recognition, pharmaceutical studies, drug discovery and disease treatment. Moreover, these play an important role in the production of improved and cost-effective medicines. Increasing scientific research activities in aptamer technology and rising participation of private organizations for the development of aptamers would boost the growth of the aptamers market globally. Furthermore, collaboration of key players to develop innovative aptamer technologies would drive market growth. For example, Aptamer Group focuses on collaborating with government agencies and academic partners for the development of effective and innovative aptamer technologies. These collaborations would establish a healthy platform for the development of aptamers, which in turn would accelerate market growth. However, strict regulations and ethical issues related to aptamers would restrain the growth of the market.

The aptamers market is segmented by types and by applications. The aptamers market by types is segmented into nucleic acid aptamers and peptide aptamers. The nucleic acid aptamers segment accounted for the largest share of the aptamers market in 2012. It is expected to dominate the market during the forecast period. Growth in this segment is attributed to increasing use of nucleic acid aptamers in research and development. Additionally, nucleic acid aptamers is projected to be the fastest growing segment during the forecast period. The aptamers market, by application is segmented into therapeutics development, diagnostics, research and development applications and others. The diagnostics application segment is likely to grow consistently due to increasing use of aptamers in biomedical diagnostics, molecular imaging and development of disease related biomarkers. However, the therapeutics development application segment is estimated to grow at the highest CAGR due to increasing research and development activities in aptamer technology to develop novel therapeutic agents.



North America accounted for the largest share of the global aptamers market in 2012. Presence of a large number of key players and increasing research and development activities in aptamer technology in North America are the major factors contributing to the growth of aptamers market. Europe accounted for the second largest share i.e., over 35% of the total market in 2012. The aptamers market is majorly driven by increasing use of aptamer technologies by small-scale industries in Europe. Asia-Pacific is expected to grow at the highest CAGR from 2013 to 2019 due to increasing initiatives undertaken by governments for the development of aptamers. There is intense competition in the global aptamers market. Manufacturers are increasing their investment in aptamer technology. The global aptamers market includes major companies such as Somalogic, Inc., NOXXAN Pharma AG, Aptamer Science, Inc. and Aptagen, Inc.

The global aptamers market is segmented into the following categories:
Aptamers Market, by Types
Nucleic Acid Aptamers
Peptide Aptamers
Aptamers Market, by Applications
Therapeutics Development
Diagnostics
Research and Development Application
Others
Aptamers Market, by Geography
North America
Europe
Asia-Pacific
Rest of World (RoW)


Key Questions This Study Will Answer

What is the market size and potential for Aptamers Market products?
Which segment of Aptamers Market is growing the fastest? How long will it continue to grow, and at what rate?
What is the greatest challenge faced by the Aptamers Market and how can it be overcome?
Are the products and services offered currently meeting customer needs, or are there additional developments needed?

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.


Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Wednesday, 25 March 2015

Agricultural Biotechnology Market - Global Industry Forecast, 2013 – 2019

Agricultural biotechnology is a collection of scientific procedures and tools that can be used on living organisms or plants or on both simultaneously to improve agricultural crop productivity. Agricultural biotechnology is majorly used to alter the genome sequence of crops and those crops can be termed as transgenic or genetically modified crops. This has benefitted farmers, producers and in turn consumers with high crop yield and good food quality. The agricultural biotechnology market has been classified based on applications into transgenic crops and synthetic biology-enabled products and tools.

Browse the full Agricultural Biotechnology Market Report: http://www.transparencymarketresearch.com/agricultural-biotechnology-market.html

The report comprises of an executive summary, which includes a market snapshot that provides overall information of the various application segments for 2012 and 2019. It also analyzes the global agricultural biotechnology market with respect to regions and application segments. It provides market share of regions and applications for 2012 and 2019.

Demand for food production has increased significantly due to rise in global population. This is one of the major drivers for growth in the agricultural biotechnology market. In addition, regulatory support in the Americas and Asia Pacific is expected to boost market growth in the next few years. Rising demand for biofuels is further boosting the market.


This report analyzes and estimates the global agricultural biotechnology market in terms of revenue (USD Million) from 2012 to 2019. The forecast period of the market is from 2013 to 2019. The market is segmented on the basis of application as transgenic crops and synthetic biology-enabled products and tools. Transgenic crops are further analyzed into major crop types as corn, soybean, cotton and others. Each of the mentioned applications is estimated and forecasted into major geographic regions as North America, Europe, Asia Pacific and Rest of the World. This market research study provides detailed quantitative and qualitative information about regional specific application segment.


The study includes a detailed analysis of each stage of the value chain. It also provides information about value added from supplier to end user industries and degree of integration. Additionally, it analyzes major driving and restraining factors of the global agricultural biotechnology market and their impact in the next few years. It also highlights opportunities during the forecast period. The report comprises of Porter’s five forces model in order to study the degree of competition in the market and the bargaining power of suppliers, bargaining power of buyers, threat from new entrants and threat from substitutes with its effect on the overall market during the forecast period. The report also includes market share of the companies present in the market in 2012. The study also comprises of market attractiveness of the agricultural biotechnology applications for the next few years. Market attractiveness has been calculated based on market size, growth rate and other socio-economical factors.



The report also includes company profiles of major players in the market. Company profiles include company overview, product portfolio, financial overview, business strategies, SWOT analysis and recent developments. Major participants analyzed in this report include Monsanto, Syngenta, Bayer CropScience, DuPont Pioneer Hi-Bred, Vilmorin, Dow AgroSciences, Evogene, KWS SAAT Ag, Certis and Mycogen Seeds among others.


We have evaluated the market value and qualitative factors such as company market share and application share with the help of secondary and primary research. Primary research includes interviews and discussions with key opinion leaders from wide range of companies. Secondary resources include agricultural biotechnology company websites, annual reports, market analysis articles, the U.S.


Department of Agriculture, the U.S. Food and Drug Administration, Environmental Protection agency, news articles and press releases related to agricultural biotechnology market.
The global agricultural biotechnology market has been estimated and forecasted using top-down approach for estimating and forecasting by geography and bottom-up approach for estimating and forecasting by application.


This report segments the global agricultural biotechnology market as follows:
Agricultural Biotechnology Market: Application Analysis
Transgenic crops
Corn
Soybean
Cotton
Others
Synthetic biology-enabled products
Tools
Agricultural Biotechnology Market: Regional Analysis
North America
Europe
Asia Pacific
Rest of the World




About us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge

Tuesday, 24 March 2015

Life Science Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Consumption of life science reagents has been increasing due to rapidly developing technologies and increasing use of life science technologies. Life science reagents are commercially available in solid as well as in liquid forms. Life science reagents market report covers the market analysis for various reagents used in the biotechnology and life sciences. Continuous innovation in biotechnology is driving the life science reagents market towards remarkable growth. The stakeholders for life science reagents market study include manufacturers and providers of life science reagents.




The global life science reagents market is categorized based on various products that are commercially available and end users of life science reagent products. The different product categories covered in the life science reagents market report include polymerase chain reaction (PCR) reagent kits, cell and tissue culture reagents, flow cytometry reagents, chromatography reagents, in-vitro diagnostic (IVD) reagents and others (gene expression reagents, mass spectroscopy reagents and transfection reagents). The end users for the life science reagents market comprise commercial and contract manufacturers, research and academic institutes, hospital and clinical laboratories and forensic laboratories. A detailed market analysis and revenue forecast for above-mentioned segments has been provided in the life science reagents market study, in terms of USD million for the period 2011 to 2019. The life science reagents market report also provides the compounded annual growth rate (CAGR %) for each product type and end user segment for the forecast period 2013 to 2019, wherein the market size estimations have been made considering 2012 as the base year.

In terms of geographical distribution, the global life science reagents market has been classified into four geographical areas, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The current and future market size (in terms of USD million) of the above mentioned regional markets has been provided in the life science reagents market report for the period 2011 to 2019 along with their growth rate (CAGR %) for the period 2013 to 2019. The life science reagents market study further offers recommendations and highlights of the current industry trends of life science reagents, which would be useful for the established and emerging players who wish to, enter the market in the near future for strengthening and securing their position in the global life science reagents market.



The executive summary of the life science reagents market report includes market snapshot of the industry. In addition, comparative analysis of the global life science reagents market by geography in terms of value % for the years 2012 and 2019 is also included in the executive summary. The market overview section of the life science reagents market report demonstrates the market dynamics and trends such as the drivers, restraints and opportunities that influence the current nature and future status of life science reagents market. Impact factors such as market attractiveness analysis by geography in terms of value (%) for the year 2012 and Porter’s five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario of the global life science reagents market.

The life science reagents market study concludes with company profiles section which includes key information such as company overview, financial information, business strategies, product portfolio, and recent developments about the major players in this market. Some of the key players profiled in the life science reagents market report include Abbott Laboratories, Agilent Technologies, Lonza Group Ltd., Promega Corporation, Sigma Aldrich Corporation, Merck Millipore, Siemens Healthcare and Bio-Rad Laboratories, Inc.

The global life science reagents market is segmented as follows:

Life Science Reagents Market, by Product Type
Polymerase chain reaction (PCR) reagent kits
Cell and tissue culture reagents
Flow cytometry reagents
Electrophoresis reagents
Chromatography reagents
In-vitro diagnostics (IVD) reagents
Others (gene expression reagents, mass spectroscopy reagents and transfection reagents)
Life Science Reagents Market, by End User
Commercial and contract manufacturers
Research and academic institutions
Clinical laboratories
Forensic laboratories
Life Science Reagents Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World



About Us



Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.



TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.



Monday, 23 March 2015

Immunoprotein Diagnostic Testing Market to Observe Increased Demand due to Rising Geriatric Population:Transparency Market Research

The global market for immunoprotein diagnostic testing is studied in a new report published by U.S.-based market research firm Transparency Market Research. The report is titled “Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”.The report states that the global immunoprotein diagnostic testing market will grow from US$11,019.7 million in 2012 to US$15,351.0 million by 2019, registering a CAGR of 5.7% between 2013 and 2019.

Browse the full Immunoprotein Diagnostic Testing Market Report at http://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html

To be able to cope up with rising incidences of diseases such as diabetes, cancer, malaria, tuberculosis, and a wide variety of viral infections, quick and reliable diagnostic methods have become essential in hospitals and diagnostic centers. The growing population of geriatrics across the globe has further added to the pool of people seeking medical attention, along with an increased prevalence of autoimmune diseases.The report segments the global immunoprotein diagnostic testing market according to four key factors – immunoprotein diagnostic testing technologies, immunoprotein diagnostic testing methods by type of immunoprotein tested, key applications areas, and key regional markets.

The report further divides the segment of technologies into enzyme based immunoassay, immunofluorescence assay, radioimmunoassay, immunoturbidity assay, immunoprotein electrophoresis, and chemiluminescence assay. Of these, the market for chemiluminescence assay enjoyed the largest market share in 2012, owing to sensitivity, ease of use, and wide scope of applications of the technique. The market for radioimmunoassay testing technique is expected to decline due to rising adoption of more effective and safer technologies such as immunofluorescence assay, chemiluminescence assay, and ELISA. Strict regulations regarding the exemption of radioactive substances from healthcare practices and the high cost of assay equipment and devices have further retrained the market for radioimmunoassay testing.

On the basis of type of immunoprotein tested, the market is further categorized into complement system protein diagnostic tests, haptoglobin diagnostic tests, free light chain diagnostic tests, immunoglobulin diagnostic tests, C-reactive protein diagnostic tests, and prealbumin diagnostic tests. Of these, the segment of C-reactive protein (CRP) diagnostic tests has garnered considerable attention in the past owing to their effectiveness in accurately diagnosing inflammation related disorders. CRP tests are also widely prescribed for the diagnosis of injuries, cardiovascular diseases, and strokes. The market for free light chain diagnostic tests is currently in its initial stages of development.




The market segment of application areas includes applications of global immunoprotein diagnostic testing market in the fields of oncology testing, infectious diseases, toxicology testing, allergy testing, endocrine testing, and autoimmune disease testing. Geographically, the market is studied according to the regional markets in North America, Asia Pacific, Europe, and the Rest of the World.

Amongst the various applications of the global immunoprotein diagnostic testing market studied by the report, applications in the field of oncology are expected to help the segment in garnering the largest share of revenue during the report’s forecast period. The report states that the oncology application segment will grow at a CAGR of 6% between 2013 and 2019, and value US$4,943.0 million by 2019.



About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


Thursday, 19 March 2015

Global Orthobiologics Market to Reach $5,519.9 Million by 2019


In its latest report, Transparency Market Research, a U.S.-based market intelligence firm states that the global orthobiologics market is estimated to be worth $ 5,519.9 million by the end of 2019. The report, titled ‘Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’also states that the market for orthobiologics across the world was worth $3,745.6 million in 2012 and will grow at a compound annual growth rate (CAGR) of 5.9% in the forecast period.


Browse the full Orthobiologics Market Report at http://www.transparencymarketresearch.com/orthobiologics-market.html


Nearly half of the population aged 50 years and above is afflicted by bone and joint disorders, and this number is expected to almost double by the year 2020. This has and will continue to increase the demand for orthobiologics. Other factors which have fueled the growth of the orthobiologics market are technological advances, declining usage of allografts and autografts in orthopedic procedures, change in lifestyle, increase in obesity cases, and rise in sports activities and sports injuries.

However, the strict regulatory requirements and lack of reimbursement are expected to restrain market growth.


According to the report, the market for orthobiologics can be segmented on the basis of products, applications, and geography.
Product: The various product types of orthobiologics include machined bones, allografts, bone morphogenetic proteins (BMPS), demineralized bone matrix (DBM), stem cell therapy, synthetic bone substitutes, and viscosupplementation.
Applications: The numerous applications of orthobiologics are trauma, spinal fusion, and reconstructive surgery.

Geography: The orthobiologics industry is classified into four main regions - North America, Europe, Asia-Pacific and Rest of the World.

Among all the products, viscosupplementation make up the largest share in the market. It is comparatively more powerful and effective as a painkiller than other pain relievers and with the number of knee treatments on the rise, demand for viscosupplementation has gone up. Bone morphogenetic proteins (BMPs) follow next in terms of market share, although its growth is likely to decline during the forecast period of 2013-2019 owing to its falling sales of INFUSE – a Medtronic product with severe side effects. Faster recovery, lower costs and no risk of transmission will enable stem cell based products and synthetic bone substitutes gain significant growth in future.



In terms of location, North America and Europe both lead the global market due to increasing popularity and demand for minimally invasive surgeries such as growth factor treatment and bone grafting. Asia-Pacific, however, is expected to witness the fastest growth rate between 2013 and 2019.

The TMR report profiles some of the major players and their contribution to the global orthobiologics market. The leading companies include Stryker Corporation, Medtronic, Inc., Wright Medical Technology, Inc., Orthofix, Inc., NuVasive, Inc., and DePuySythes.


About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Monday, 16 March 2015

Synthetic Biology Market to Surge Ahead at 32.6% CAGR From 2013 - 2019 Supported by Healthcare Applications

Synthetic biology is on the path to becoming a US$13.4 billion market by 2019, exhibiting a sharp CAGR of 32.6% between 2013 and 2019, estimates Transparency Market Research in its latest report. The report, titled “Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019”, puts the value of the market at US$1.8 billion in 2012.Synthetic biology is a process that utilizes biology and genetic engineering to produce artificial biological systems and devices. The process is proving to be especially pivotal in producing affordable medicines and improved nutritional products. The report zeroes in the following key factors that have shaped the growth curve of the global synthetic biology market: Increased government participation and investments being routed into scientific research as well as active initiatives taken by private players in R&D.

Browse the full Synthetic Biology Market Report at http://www.transparencymarketresearch.com/synthetic-biology-market.html


Besides pharmaceutical and nutrition-related applications, synthetic biology has been used for mitigating the damaging effects of marine pollution. The process has been extensively applied for developing engineered microorganisms to limit oil spill damages. Additionally, researchers have successfully used synthetic biology to convert regular plastics into microplastics that can be re-used. With DNA sequencing prices taking a plunge, the synthetic biology market will gain momentum. However, the global synthetic biology market is still impeded by ethical issues relating to synthetic biology products.
Synthetic Biology Market Segmentation by Product, Application, and Technology

The TMR reports offers a highly detailed study of the global synthetic biology market by classifying it on three fronts: Application, products and technologies.
By application, the synthetic biology market is classified according to sectors such as: Healthcare, chemicals, agriculture and others. Of these, the healthcare segment will demonstrate continued growth thanks to factors such synthetic DNA and genes now being commercially available, which in turn supports the development of affordable pharma products.

The segmentation of the synthetic biology market by product has been done as follows: Core products and enabling products. The core products segment is further segregated as: XNA, synthetic DNA, synthetic cells, synthetic genes, and chassis organisms. The enabling products segment, on the other hand, is further divided into products for oligonucleotide synthesis and those for DNA synthesis. According to 2012 estimates, the core products segment enjoyed a larger share of market revenues as compared to enabling products. Based on the type of technology used in synthetic biology processes, the market is segmented as: Biological components and integrated systems, genome engineering, bioinformatics, and DNA sequencing. Technology for synthetic biology genome engineering is observed to be the most widely used as of 2012, because it can efficiently modify specific areas within the DNA to attain better reproducibility.




Regional and Competitive Analysis of the Synthetic Biology Market

Findings of the TMR report indicate that Europe will lead the synthetic biology market through the forecast period as a result of active government initiatives and milestones achieved by private players. North America followed Europe in terms of market share as of 2012 through the launch of innovative technologies. Players that yield maximum influence over the synthetic biology market are: DuPont, Inc., Bayer AG, Amyris, Inc., Ginkgo Bioworks, Royal DSM, and Life Technologies Corporation.



About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


Sunday, 15 March 2015

Polymerase Chain Reaction: Commercial Labs Provide Solution to Restricted Global Market:Transparency Market Research

Kary Mullis in the 1980s developed a revolutionary technique that is now the basis of the global polymerase chain reaction (PCR) market. The basic concept of PCR is to use a DNA polymerase to synthesize completely new strands of DNA. These strands will be similar to the template DNA strand used. One of the core requirements in the process is the addition of a primer. This is required because a DNA polymerase can only add a nucleotide to a 3’-OH group that already exists. The primer helps the polymerase to add the first nucleotide. Using this method, a scientist can create billions of copies of any specific sequence he/she wants. The core components of PCR are therefore a DNA template, a DNA polymerase, and nucleotides.

Browse Full Global Polymerase Chain Reaction Market Report With Complete TOC @ http://www.transparencymarketresearch.com/pcr-technologies.html


The techniques used in the global PCR market have created a giant scope of innovation in the world of science in terms of DNA-based research molecular diagnostics. PCR allows for the absolute quantification of DNA and RNA, both of which are genetic materials.

Commercial Labs Boost the Global PCR Market

Till recent times, the global PCR market has found scope mostly in pharma and biotechnology industries apart from research institutions. The rise of commercial diagnostic laboratories is set to change this confined trend. A large number of labs, both private commercial and government, are beginning to prefer PCR for the accurate diagnosis of life-threatening diseases including cancer and Ebola. Large players in the diagnostics industry are now building standalone labs with minimal infrastructure to provide PCR.

Player Trends and Innovations that Drive the Global PCR Market

All the top companies that operate in the global PCR market are currently working on developments that enhance the functionalities in it. This includes creating a broader list of tests and a higher level of specificity and sensitivity. Some of the key innovations that have defined the global PCR market today are the significant reduction in turnaround time, the ability to create automated workflow, and higher productivity. All developments in the global PCR market focus on the fact that there needs to be an extremely high level of accuracy in the detection and amplification of genetic materials.

There is a major shift in technologies happening in the global PCR market. This involves the increasing preference of real time and/or digital PCR systems. The market’s innovations will create a stronger foundation for future activities. For example, the introduction of QX200 Droplet Digital PCR system by Bio-Rad offers a plethora of tests for molecular diagnostics. Their improved workflow will reduce overall costs in the global PCR market.


Reagents and Consumables Dominate the Global PCR Market

The largest products segment in the 2013 global PCR market was reagents and consumables, when it generated a total of US$4,072.2 million for multiple companies. As for the applications segment, more than 48% of the 2013 global PCR market was held by life sciences. Clinical diagnostics held more than 33% of the market share in the same category. Life sciences dominates this category due to a greater level of acceptance of PCR oriented methods in cancer research, which happens to be one of the oldest application segments in the global PCR market. Academics and research has remained the largest end user of the global PCR market for the longest time and continued its dominance till 2013.

The global polymerase chain reaction market had a past worth of US$6.1 billion at the end of 2013. Market analysts now say that this market is currently developing at a compound annual growth rate of 6.6% between 2014 and 2020. If this growth rate remains unchanged, the global polymerase chain reaction market could potentially be worth US$9.6 billion by 2020. With its wide application base and growing number of commercial labs, the market is set to show a good deal of promise to all the players in it.



About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact:
Mr.Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Website: http://www.transparencymarketresearch.com/



Friday, 13 March 2015

Molecular Cytogenetics Market to reach US$1.9 Billion by 2019 due to Rapid Growth in Asia Pacific: Transparency Market Research

A new report published by Transparency Market Research (TMR) is titled “Molecular Cytogenetics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”. The report discusses the primary growth drivers, market restraints, trends, and dynamics of the global market. Additionally, it points out the strengths, weaknesses, opportunities, and threats that the global molecular cytogenetics market faces. According to the report, the global molecular cytogenetics market was estimated at US$469.2 million in 2012 and is anticipated to reach US$1.9 billion in 2019, developing at a CAGR of 23.4% between 2013 and 2019.


Browse the full Molecular Cytogenetics Market Report at http://www.transparencymarketresearch.com/molecular-diagnostics-market.html


The global molecular cytogenetics market is segmented on the basis of technology and geography. The technology segment of the global molecular cytogenetics market comprises FISH and aCGH. These techniques form the backbone of gene discovery, gene mapping, and complex disease trait analysis. Molecular cytogenetics enables pathologists to understand diseases in greater detail. It enables them to make an accurate diagnosis and prognosis of diseases related to hematological malignancies and solid tumors at a molecular level.


Today the cytogenetics field stretches from identification of chromosome structure to assessment of structural and functional genetic anomalies. FISH holds the largest share in the global molecular cytogenetics market as it allows interpretation of information at a genome level. The reason FISH enjoys such a huge share is that it offers an accurate, speedy, sensitive, and high-resolution result. This segment is likely to grow in the coming years due to technological advancements such as digital imaging and enhanced fluroscence microscopes. The FISH segment in the global molecular cytogenetics market will also be encouraged by the increasing investment in the field of bioinformatics and genomics. The aCGH technique has also been gaining pace along with FISH as it offers a higher resolution result. Analysts predict this segment will grow at a CAGR of more than 20% in the coming few years.



Geographically, the global molecular cytogenetics market is divided into North America, Europe, Asia Pacific, and Rest of the World. Presently, North America holds the largest share in the global molecular cytogenetics market, closely followed by Europe. The growth in these regions is fueled by increasing public awareness and a huge pool of research laboratories. This growth can also be attributed to rising incidences of chronic diseases such as cancer and the subsequent need for personalized medicines.


Analysts predict that Asia Pacific will grow at a rapid pace in the coming few years. Huge population base and educated public will drive this market as well. Additionally, genetically transmitted disorders due to consanguineous marriages in these regions will accelerate the growth of the molecular cytogenetics market.




The global molecular cytogenetics market consists of key players such as Agilent Technologies Inc., Abbott Laboratories, Affymetrix, Inc., Applied Spectral Imaging, Illumina, Inc., and Life Technologies Corporation.





About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.


TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Tuesday, 3 March 2015

Polymerase Chain Reaction Market - Global Industry Forecast 2014 – 2020


Polymerase chain reaction (PCR) enables DNA sequencing and helps in determining the order of its building blocks. PCR finds applications in disease diagnosis, forensic sciences, and identification of bacteria and viruses. PCR is an excellent technique for rapid detection of microbial contamination and pathogens, including those complicated to culture. These techniques are precise and robust methods that rely on polymerase enzyme to amplify trace amounts of DNA/RNA fragments by creating several identical or near-identical copies. The demand for greater efficiency and productivity in the pharmaceutical industry has led to the growth of this market.

Browse the full Polymerase Chain Reaction Market Report:


The report on the global PCR Market studies the global PCR market in terms of products, end-users, applications and geography. Each of these segments has been analyzed in detail for market trends, recent developments, outlook and opportunities and various applications. The report provides the market size in terms of value (USD million) for each segment and sub-segment for the period from 2012 to 2020, considering the macro- and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the segments has also been included in the report for the forecast period from 2014 to 2020, considering 2012 and 2013 as the base years.

The PCR products studied in this report include instruments, and reagents and consumables. Instruments are further classified by type such as standard PCR, quantitative real time PCR (qPCR) and digital PCR (dPCR). Pharmaceutical and biotech industries, clinical diagnostic laboratories, hospitals, academics and public research organizations are the major end-users of the global PCR market. PCR Applications segment has been further categorized as clinical diagnostics, life sciences and others such as forensic sciences, agriculture and nanotoxicity studies.

Geographically, the market has been segmented into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast in terms of value (USD Million) for each of these regions along with the CAGR for the forecast period from 2014 to 2020 have been provided in the report. A detailed qualitative analysis of the major factors determining market dynamics such as drivers, restraints and opportunities, along with the market attractiveness analysis are discussed in the market overview section of the report. The study provides a list of recommendations for new companies willing to enter the market and for existing companies to increase market shares, which is likely to help in the decision-making process. Event impact analysis has also been provided in this report that will help in understanding the major events impacting the PCR market growth.

The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interaction via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases for patents, clinical trials, demographics, disease incidence/prevalence, etc. For estimating the market size in terms of value, revenue generation by the PCR instruments, and reagents and reaction consumables has been considered. Most of the leading players in the PCR market manufacture both consumables as well as instruments. The level of product differentiation plays a major role in determining the market position of these players. Several players are trying to enter and establish themselves in the PCR market, especially in emerging economies. Major players operating in this market are Affymetrix, Inc., Agilent Technologies, Inc., Sigma Aldrich Corporation, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, GE Healthcare, QIAGEN, Becton Dickinson & Company and Thermo Fischer Scientific.




The global PCR market is segmented as follows:
Global PCR Market Revenue (USD Million), by Products
Instruments
Standard PCR Systems
Real Time PCR Systems
Digital PCR Systems
Reagents and Consumables
Global PCR Market Revenue (USD Million), by End-Users
Pharmaceutical and Biotechnology Industries
Clinical Diagnostics Labs and Hospitals
Academic and Research Organizations
Global PCR Market Revenue (USD Million), by Applications
Clinical Diagnostics
Life Sciences
Others
Global PCR Market Revenue (USD Million), by Geography
North America
Instruments
Reagents and Consumables
Europe
Instruments
Reagents and Consumables
Asia Pacific
Instruments
Reagents and Consumables
Rest of World
Instruments
Reagents and Consumables




About Us



Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.



Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.



Contact

Mr. Nachiket Ghumare
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com